# Genetics Resources

## Novartis Spinal Muscular Atrophy (SMA)

[FDA Approval](https://www.asgct.org/research/news/may-2019/fda-approves-zolgensma-gene-therapy)

[Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy](https://www.nejm.org/doi/full/10.1056/NEJMoa1706198) by Mendell et. al., The New England Journal of Medicine Nov 2, 2017.

[Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy](https://onlinelibrary.wiley.com/doi/full/10.1002/ppul.24203) Dec 2018 by Samiah Al‐Zaidy MD et. al.

## Gene Therapies

[FDA trials for gene and cell therapies](https://app.emergingmed.com/asgct/home/)

[AAV therapy examplation](https://www.jmcp.org/doi/10.18553/jmcp.2018.24.12-a.s3)

## Recommended Reading

[The gene therapy revolution is here. Medicine is scrambling to keep pace](https://theconversation.com/the-gene-therapy-revolution-is-here-medicine-is-scrambling-to-keep-pace-118329) June 4, 2019 by Elizabeth Finkel, La Trobe University
